RDY 572 (Fexofenadine and Pseudoephedrine Extended Release 180 mg / 240 mg)

Pill imprint RDY 572 has been identified as Fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release 180 mg / 240 mg.

Fexofenadine/pseudoephedrine is used in the treatment of hay fever and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Fexofenadine/pseudoephedrine 180 mg / 240 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for RDY 572

Fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release 180 mg / 240 mg RDY 572
Fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release
Imprint:
RDY
572
Strength:
180 mg / 240 mg
Color:
White
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Upper respiratory combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Dr. Reddy’s Laboratories Limited
National Drug Code (NDC):
55111-0572
Inactive Ingredients:
acetyltributyl citrate
croscarmellose sodium
silicon dioxide colloidal
ethylcelluloses
copovidone
hypromelloses
microcrystalline cellulose
polyethylene glycol
sodium stearyl fumarate
magnesium silicate
titanium dioxide
hydrogenated cottonseed oil

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)